← 研踪 PaperTrailarXiv:2610.14226 · v2
CAPTOR: a vision-language foundation model for Chest-Abdomen-Pelvis Oncologic CT
CAPTOR:用于胸腹盆腔肿瘤CT的视觉-语言基础模型
首次提交 2026-10-10 02:39
版本更新 2026-11-19 01:38
雷达观测 2026-11-19 15:04
摘要
Objectives: Radiologists interpreting oncologic chest-abdomen-pelvis (CAP) CT must also detect non-oncologic conditions, yet existing CT foundation models are trained on single anatomical regions or on non-oncologic data. We developed and evaluated CAPTOR, a vision-language foundation model for oncologic CAP CT that uses an anatomically structured preprocessing strategy to learn from whole examinations. Materials & Methods: CAPTOR is a contrastive vision-language model pretrained on 25,512 predominantly oncologic CAP CT-report pairs (single or multiple series) from a retrospective multicenter dataset (North America, Europe, Asia). It was compared with five CT foundation models, a larger-scale variant (CAPTOR-100K) and an ablation without anatomical preprocessing (CAPTOR-NoPre) on classification and retrieval using held-out internal and public test sets, and on survival prediction using TumorImagingBench. Confidence intervals and pairwise comparisons used patient-level bootstrap and permutation tests. Results: On 10,794 test studies, CAPTOR achieved higher AUC than all five models on CAP (0.767 vs. 0.695 for the next-best model; p<0.001) and oncologic subsets (0.784 vs. 0.734; p<0.001), with superior retrieval on both, and ranked first on three of four oncologic survival benchmarks. Despite substantially fewer training examinations, it performed comparably to CAPTOR-100K. Removing the anatomically structured preprocessing reduced classification performance, including on the institutionally held-out test subset (macro-AUC 0.737 vs. 0.691 for CAPTOR-NoPre, p<0.01). Conclusion: Anatomically structured preprocessing enabled whole-examination CAP CT interpretation, including multiple-series acquisitions, and improved downstream performance. CAPTOR outperformed state-of-the-art CT foundation models on CAP and oncologic subsets while matching a substantially larger-scale variant.
观测到的版本
相邻记录可能跳过中间版本;首次发现 v2 及以上也会标为版本更新。
v2 · 2026-11-19 01:38 · 最新观测版本
CAPTOR: a vision-language foundation model for Chest-Abdomen-Pelvis Oncologic CT
Objectives: Radiologists interpreting oncologic chest-abdomen-pelvis (CAP) CT must also detect non-oncologic conditions, yet existing CT foundation models are trained on single anatomical regions or on non-oncologic data. We developed and evaluated CAPTOR, a vision-language foundation model for oncologic CAP CT that uses an anatomically structured preprocessing strategy to learn from whole examinations. Materials & Methods: CAPTOR is a contrastive vision-language model pretrained on 25,512 predominantly oncologic CAP CT-report pairs (single or multiple series) from a retrospective multicenter dataset (North America, Europe, Asia). It was compared with five CT foundation models, a larger-scale variant (CAPTOR-100K) and an ablation without anatomical preprocessing (CAPTOR-NoPre) on classification and retrieval using held-out internal and public test sets, and on survival prediction using TumorImagingBench. Confidence intervals and pairwise comparisons used patient-level bootstrap and permutation tests. Results: On 10,794 test studies, CAPTOR achieved higher AUC than all five models on CAP (0.767 vs. 0.695 for the next-best model; p<0.001) and oncologic subsets (0.784 vs. 0.734; p<0.001), with superior retrieval on both, and ranked first on three of four oncologic survival benchmarks. Despite substantially fewer training examinations, it performed comparably to CAPTOR-100K. Removing the anatomically structured preprocessing reduced classification performance, including on the institutionally held-out test subset (macro-AUC 0.737 vs. 0.691 for CAPTOR-NoPre, p<0.01). Conclusion: Anatomically structured preprocessing enabled whole-examination CAP CT interpretation, including multiple-series acquisitions, and improved downstream performance. CAPTOR outperformed state-of-the-art CT foundation models on CAP and oncologic subsets while matching a substantially larger-scale variant.
查看此版本解读 →查看此版本原文 ↗